169 related articles for article (PubMed ID: 26815784)
1. Osteogenesis Imperfecta Type VI in Individuals from Northern Canada.
Ward L; Bardai G; Moffatt P; Al-Jallad H; Trejo P; Glorieux FH; Rauch F
Calcif Tissue Int; 2016 Jun; 98(6):566-72. PubMed ID: 26815784
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up in osteogenesis imperfecta type VI.
Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
[TBL] [Abstract][Full Text] [Related]
3. Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI.
Wang JY; Liu Y; Song LJ; Lv F; Xu XJ; San A; Wang J; Yang HM; Yang ZY; Jiang Y; Wang O; Xia WB; Xing XP; Li M
Calcif Tissue Int; 2017 Jan; 100(1):55-66. PubMed ID: 27796462
[TBL] [Abstract][Full Text] [Related]
4. The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI.
Al-Jallad H; Palomo T; Roughley P; Glorieux FH; McKee MD; Moffatt P; Rauch F
Bone; 2015 Jul; 76():115-20. PubMed ID: 25868797
[TBL] [Abstract][Full Text] [Related]
5. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI.
Rauch F; Husseini A; Roughley P; Glorieux FH; Moffatt P
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1550-6. PubMed ID: 22669302
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.
Belinsky GS; Sreekumar B; Andrejecsk JW; Saltzman WM; Gong J; Herzog RI; Lin S; Horsley V; Carpenter TO; Chung C
FASEB J; 2016 Aug; 30(8):2837-48. PubMed ID: 27127101
[TBL] [Abstract][Full Text] [Related]
7. Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice.
Rajagopal A; Homan EP; Joeng KS; Suzuki M; Bertin T; Cela R; Munivez E; Dawson B; Jiang MM; Gannon F; Crawford S; Lee BH
Mol Genet Metab; 2016 Mar; 117(3):378-82. PubMed ID: 26693895
[TBL] [Abstract][Full Text] [Related]
8. Extremely low level of serum pigment epithelium-derived factor is a special biomarker of Chinese osteogenesis imperfecta patients with SERPINF1 mutations.
Wang JY; Li LJ; Zhang Q; Liu Y; Lv F; Xu XJ; Song YW; Wang O; Jiang Y; Xia WB; Xing XP; Li M
Clin Chim Acta; 2018 Mar; 478():216-221. PubMed ID: 29104038
[TBL] [Abstract][Full Text] [Related]
9. A co-occurrence of osteogenesis imperfecta type VI and cystinosis.
Tucker T; Nelson T; Sirrs S; Roughley P; Glorieux FH; Moffatt P; Schlade-Bartusiak K; Brown L; Rauch F
Am J Med Genet A; 2012 Jun; 158A(6):1422-6. PubMed ID: 22528245
[TBL] [Abstract][Full Text] [Related]
10. Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen.
Venturi G; Gandini A; Monti E; Dalle Carbonare L; Corradi M; Vincenzi M; Valenti MT; Valli M; Pelilli E; Boner A; Mottes M; Antoniazzi F
J Bone Miner Res; 2012 Mar; 27(3):723-8. PubMed ID: 22113968
[TBL] [Abstract][Full Text] [Related]
11. Mutations in SERPINF1 cause osteogenesis imperfecta type VI.
Homan EP; Rauch F; Grafe I; Lietman C; Doll JA; Dawson B; Bertin T; Napierala D; Morello R; Gibbs R; White L; Miki R; Cohn DH; Crawford S; Travers R; Glorieux FH; Lee B
J Bone Miner Res; 2011 Dec; 26(12):2798-803. PubMed ID: 21826736
[TBL] [Abstract][Full Text] [Related]
12. Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis.
Kang H; Aryal Ac S; Barnes AM; Martin A; David V; Crawford SE; Marini JC
J Bone Miner Res; 2022 May; 37(5):925-937. PubMed ID: 35258129
[TBL] [Abstract][Full Text] [Related]
13. Osteogenesis imperfecta Type VI with severe bony deformities caused by novel compound heterozygous mutations in SERPINF1.
Cho SY; Ki CS; Sohn YB; Kim SJ; Maeng SH; Jin DK
J Korean Med Sci; 2013 Jul; 28(7):1107-10. PubMed ID: 23853499
[TBL] [Abstract][Full Text] [Related]
14. Normal bone density and fat mass in heterozygous SERPINF1 mutation carriers.
Al-Jallad H; Palomo T; Moffatt P; Roughley P; Glorieux FH; Rauch F
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2446-50. PubMed ID: 25127091
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.
Becker J; Semler O; Gilissen C; Li Y; Bolz HJ; Giunta C; Bergmann C; Rohrbach M; Koerber F; Zimmermann K; de Vries P; Wirth B; Schoenau E; Wollnik B; Veltman JA; Hoischen A; Netzer C
Am J Hum Genet; 2011 Mar; 88(3):362-71. PubMed ID: 21353196
[TBL] [Abstract][Full Text] [Related]
16. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor.
Farber CR; Reich A; Barnes AM; Becerra P; Rauch F; Cabral WA; Bae A; Quinlan A; Glorieux FH; Clemens TL; Marini JC
J Bone Miner Res; 2014 Jun; 29(6):1402-11. PubMed ID: 24519609
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI.
Trejo P; Rauch F; Ward L
J Musculoskelet Neuronal Interact; 2018 Mar; 18(1):76-80. PubMed ID: 29504582
[TBL] [Abstract][Full Text] [Related]
18. Treatment response to long term antiresorptive therapy in osteogenesis imperfecta type VI: does genotype matter?
Celik NB; Gonc N; Ozon A; Alikasifoglu A; Rauch F; Kandemir N
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1617-1624. PubMed ID: 33031053
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations of the SERPINF1 and FKBP10 genes in Chinese families with autosomal recessive osteogenesis imperfecta.
Zhang H; Xu Y; Yue H; Wang C; Gu J; He J; Fu W; Hu W; Zhang Z
Int J Mol Med; 2018 Jun; 41(6):3662-3670. PubMed ID: 29512769
[TBL] [Abstract][Full Text] [Related]
20. [Genotypes and phenotypes of nine Uygur children with osteogenesis imperfecta in Xinjiang].
Luo YF; Dilihuma J; Sun GH; Reyilanmu B; Liang L; Du XY; Mireguli M
Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):135-139. PubMed ID: 32102151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
